WCM Investment Management LLC Sells 73,227 Shares of ICU Medical, Inc. $ICUI

WCM Investment Management LLC lowered its position in ICU Medical, Inc. (NASDAQ:ICUI) by 44.3% during the first quarter, Holdings Channel reports. The firm owned 91,996 shares of the medical instruments supplier’s stock after selling 73,227 shares during the period. WCM Investment Management LLC’s holdings in ICU Medical were worth $11,534,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the company. Millennium Management LLC raised its stake in ICU Medical by 173.4% during the third quarter. Millennium Management LLC now owns 1,089,017 shares of the medical instruments supplier’s stock worth $130,638,000 after buying an additional 690,694 shares during the last quarter. Norges Bank acquired a new stake in ICU Medical during the 4th quarter worth about $58,083,000. Thrivent Financial for Lutherans raised its position in shares of ICU Medical by 1,604.0% in the 4th quarter. Thrivent Financial for Lutherans now owns 303,457 shares of the medical instruments supplier’s stock worth $43,294,000 after acquiring an additional 285,648 shares in the last quarter. UBS Group AG lifted its stake in shares of ICU Medical by 239.8% in the 3rd quarter. UBS Group AG now owns 386,555 shares of the medical instruments supplier’s stock valued at $46,371,000 after purchasing an additional 272,782 shares during the period. Finally, Brown Advisory Inc. acquired a new position in shares of ICU Medical in the 4th quarter valued at about $32,445,000. 96.10% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

ICUI has been the subject of several recent analyst reports. Zacks Research raised ICU Medical from a “hold” rating to a “strong-buy” rating in a research note on Monday, June 29th. Jefferies Financial Group upgraded ICU Medical to a “strong-buy” rating in a report on Thursday, May 7th. KeyCorp lowered their price objective on shares of ICU Medical from $180.00 to $164.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. BTIG Research assumed coverage on shares of ICU Medical in a research report on Monday, June 15th. They set a “buy” rating and a $170.00 target price on the stock. Finally, Needham & Company LLC upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $165.00 price target for the company in a report on Wednesday, May 27th. Three investment analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, ICU Medical currently has an average rating of “Buy” and an average price target of $168.40.

ICU Medical Stock Down 0.1%

Shares of NASDAQ:ICUI opened at $157.34 on Tuesday. The business’s 50 day simple moving average is $141.41 and its two-hundred day simple moving average is $139.29. The firm has a market cap of $3.93 billion, a P/E ratio of 85.05, a PEG ratio of 2.20 and a beta of 0.76. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.17 and a current ratio of 2.34. ICU Medical, Inc. has a 52-week low of $107.00 and a 52-week high of $162.85.

ICU Medical (NASDAQ:ICUI) last released its quarterly earnings data on Thursday, May 7th. The medical instruments supplier reported $1.97 EPS for the quarter, beating the consensus estimate of $1.78 by $0.19. ICU Medical had a return on equity of 7.50% and a net margin of 2.15%.The firm had revenue of $525.77 million during the quarter, compared to the consensus estimate of $520.65 million. During the same quarter in the previous year, the company posted $1.72 earnings per share. The company’s quarterly revenue was down 12.3% on a year-over-year basis. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. As a group, research analysts forecast that ICU Medical, Inc. will post 6.51 EPS for the current fiscal year.

Insider Buying and Selling at ICU Medical

In other news, VP Virginia Ruth Sanzone sold 2,447 shares of ICU Medical stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $124.08, for a total transaction of $303,623.76. Following the completion of the transaction, the vice president directly owned 19,460 shares in the company, valued at $2,414,596.80. This trade represents a 11.17% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director David C. Greenberg sold 2,424 shares of the business’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $122.91, for a total transaction of $297,933.84. Following the sale, the director directly owned 7,960 shares of the company’s stock, valued at approximately $978,363.60. The trade was a 23.34% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 2.10% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.